Our Additional Services:

Gait Analysis

The Gait Laboratory of the Clinic for Neurology Hirslanden

Bipedal walking (“upright walking on two legs”) is the most natural, but also one of the most complex movements of human beings. This ability developed in our ancestors about 2 million years ago and made further specific human skills possible, such as the free use of hands while walking. Gait disorders can therefore have a very large negative impact on the ability to cope with everyday tasks.

Our gait laboratory is an independent diagnostic facility located at our clinic at the Medical Center Hirslanden, Seefeld. Here we offer all of our patients a comprehensive gait and balance examination. This is important to identify the cause of gait disorders and to make appropriate treatment decisions. In addition, a gait examination can sometimes lead to improved diagnosis of diseases that are not usually associated with walking. For example, gait examinations may help in diagnosing dementia. Finally, regular and accurate gait examinations are important for therapy decisions for various chronic neurological conditions, especially for neurodegenerative diseases (dementia, Parkinson’s, ataxia) or for polyneuropathy. This allows us to then develop an optimal treatment plan in collaboration with physiotherapists.

What to expect at our gait laboratory:

Our gait laboratory team, led by Ms. MSc. Magdalena Bogucka (specialist in physiotherapy), will welcome you and conduct a series of examinations tailored to your specific situation and health needs. The following specialized systems are used:

  • Walker View – Treadmill-based movement analysis device with automated analytics of the movements of the entire body.
  • Prokin Posturography – Measurement platform for posture and balance reactions in standing and sitting – used for the evaluation of balance and stability. It is also helpful in assessing fall risk.
  • NUSHU gait analysis system – Special shoes equipped with integrated sensors for measuring and evaluating gait and various gait disturbances under different conditions.

 

Privacy
Thank you for visiting www.bmg-swiss.ch, the website of Bellevue Medical Group AG in Switzerland. We use technologies from partners (3) to provide our services. These include cookies and third-party tools to process some of your personal data. These technologies are not strictly necessary for the use of the website, but they do enable us to provide a better service and to interact more closely with you. You can adjust or withdraw your consent at any time.
Vendors (non IAB) (3 Vendors)
Google Ireland Limited, Ireland


Google Tag Manager (USA)
Purpose: Initiating, controlling and maintenance of further services
rocessing operations: Collection of connection data and data of your web browser; analysis for advancement of the service
Joint controller: Google LLC, Amphitheatre Parkway, Mountain View, CA 94043, USA
Legal basis of processing: voluntary, revocable consent at any time
Consequences of not consenting: No immediate impact on the website’s function
Legal basis of data transfer to the US: Data will be transmitted to the United States on the basis of your consent according to Art. 49 (1) (a) in conjunction with Art. 6 (1) (a) GDPR. The United States have not adopted data protection standards in conformity with EU requirements. In particular US intelligence agencies will be able to access your data without informing you hand without you and without you being able to take legal action. For this reason, the European Court of Justice has issued a judgment by which it invalidated the previous adequacy decision.

Google LLC, USA

Purpose: Failure analysis, statistical analysis of our website
rocessing operations: Collection of connection data, of data of your web browser and data of accessed content; execution of analysis software and storing of data on your terminal device, anonymization of collected data; analysis of anonymous data in the form of statistics
Storage period: Data on your device for up to two years.
Joint controller: Google LLC, Amphitheatre Parkway, Mountain View, CA 94043, USA
Legal basis of processing: voluntary, revocable consent at any time
Consequences of not consenting: No immediate impact on the website’s function, but limited possibilities of further development and failure analysis
Legal basis of data transfer to the US: Data will be transmitted to the United States on the basis of your consent according to Art. 49 (1) (a) in conjunction with Art. 6 (1) (a) GDPR. The United States have not adopted data protection standards in conformity with EU requirements. In particular US intelligence agencies will be able to access your data without informing you hand without you and without you being able to take legal action. For this reason, the European Court of Justice has issued a judgment by which it invalidated the previous adequacy decision.

Meta Platforms Ireland Ltd., Ireland

Purpose: Provision of Instagram services
rocessing operations: Collection of connection data, of data of your web browser and data of accessed content; placing of advertising cookies by Facebook; processing of collected data by Facebook
Storage period: Data on your device for up to two years
Joint controller: Meta Platforms Ireland Ltd., 4 Grand Canal Square, Grand Canal Harbour, Dublin 2, Ireland
Legal basis of processing: voluntary, revocable consent at any time
Consequences of not consenting: The Instagram service will not be made available.
Legal basis for the transmission of data to the USA:The Facebook group will transmit your personal data to the United States. Data will be transmitted to the United States on the basis of your consent according to Art. 49 (1) (a) in conjunction with Art. 6 (1) (a) GDPR. The United States have not adopted data protection standards in conformity with EU requirements. In particular US intelligence agencies will be able to access your data without informing you hand without you and without you being able to take legal action. For this reason, the European Court of Justice has issued a judgment by which it invalidated the previous adequacy decision.

asd as asd